Cambridge Epigenetix Ltd
https://cambridge-epigenetix.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Cambridge Epigenetix Ltd
Cambridge Epigenetix Boosts Senior Leadership Team With New Hires
Cambridge Epigenetix Ltd. (CEGX) has appointed two new senior executives to help drive development of its epigenetics-based diagnostic technologies. Hayden Jeffreys joins the company as COO and Joanne Mason as vice president of biomarker discovery.
Pacts In Medtech: March/April 2017
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bi-monthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in March and April 2017.
Execs On The Move, April 2017
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Venture Funding Deals, April 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a monthly review of emerging In Vitro Diagnostic, Medical Device, and Pharmaceutical companies that have received venture funding. This month’s column covers deals announced February through March 2016.
Company Information
- Industry
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice